IL17A and systemic lupus erythematosus: SLE Patients Have Increased Levels of IL-6, IL-17, and IL-21 Pro-Inflammatory Cytokines. Plasma Estradiol Levels Positively Correlates With IL-6 and IL-21, and Plasma IL-21 Levels With SLE Disease Activity Index (SLEDAI) Scores.